1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Post-stroke: new trials by email Literature Review of Post-stroke trials Research Report on Post-stroke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions IncobotulinumtoxinA (100 Units), IncobotulinumtoxinA (75 Units), Placebo - Chronic Troublesome Sialorrhea, Parkinson's Disease | Phase 3 | Completed | Merz Pharmaceuticals GmbH | 184 | 2014-04-01 | 2018-03-27 |
Brain Injuries, Traumatic (1) · Parkinson Disease (1)
Basal Ganglia Diseases (1) · Brain Diseases (1) · Brain Injuries (1) · Central Nervous System Diseases (1) · Craniocerebral Trauma (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Parkinsonian Disorders (1) · Synucleinopathies (1) · Trauma, Nervous System (1) · Wounds and Injuries (1)
Botulinum Toxins, Type A (1) · incobotulinumtoxinA (1)
Germany (1) · Poland (1)